|
Index of reports
> Cases resulting in hospitalization (57)
Below is the selection of adverse event reports related to Botox (Botulinum Toxin Type A) that includes cases resulting in hospitalization.
Reports 1 - 25 of 57 Next >>
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from Japan on 2007-10-24
Patient: male
Adverse reactions / side effects: Nephrolithiasis, Urinary Tract Infection, Benign Prostatic Hyperplasia
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: unk, single
Indication: Drug USE FOR Unknown Indication
Start date: 2007-06-26
End date: 2007-06-26
Botox
Dosage: unk, single
Indication: Drug USE FOR Unknown Indication
Start date: 2007-06-26
End date: 2007-06-26
Botox
Dosage: unk, single
Indication: Drug USE FOR Unknown Indication
Start date: 2007-09-18
End date: 2007-09-18
Adverse event in receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-24
Patient:
Adverse reactions / side effects: Abdominal Pain, Oral Intake Reduced, Weight Decreased, Dysphagia, Pneumonia Aspiration, Incorrect Dose Administered, Muscular Weakness, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: 1370 units, single
Indication: Cerebral Palsy
Start date: 2007-09-18
End date: 2007-09-18
Botox
Indication: Muscle Spasticity
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from United States on 2007-10-19
Patient: female
Adverse reactions / side effects: Facial Paresis, Dysphagia, Vomiting, Aspiration, Dehydration, Urinary Tract Infection, Salivary Hypersecretion, Constipation
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: 25 units, single
Indication: Drooling
Start date: 2007-09-12
End date: 2007-09-12
Botox
Indication: Mucopolysaccharidosis IV
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-19
Patient: female
Adverse reactions / side effects: Endocarditis Bacterial, Bacteraemia, Sepsis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from Finland on 2007-10-18
Patient: female
Adverse reactions / side effects: Dysphagia
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-17
Patient: female
Adverse reactions / side effects: Sepsis, Endocarditis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-12
Patient: female
Adverse reactions / side effects: Urinary Tract Infection, Mediastinitis, Chest Pain, Pharyngolaryngeal Pain, Pyrexia, Oesophageal Ulcer
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Other drugs received by patient: Pethidin; Midazolam HCL; Glyburide; Insulin
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-11
Patient: male, weighing 86.2 kg (189.6 pounds)
Adverse reactions / side effects: Blood Pressure Increased, Dysphagia, Dyspnoea, Pain in Extremity, Headache, Muscle Spasticity, Mantle Cell Lymphoma, Anxiety, Dysarthria, Malaise, Fatigue, Dysphonia, Neck Pain, Dizziness
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: 400 units, single
Indication: Pain
Start date: 2007-02-06
End date: 2007-02-06
Botox
Indication: Dystonia
Other drugs received by patient: Celebrex; Tylenol W / Codeine NO. 3
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-10
Patient: male, weighing 88.0 kg (193.6 pounds)
Adverse reactions / side effects: Cellulitis, Pain, Oedema
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: unk, single
Indication: Muscular Weakness
Start date: 2007-02-01
End date: 2007-02-01
Temozolomide
Dosage: 145 mg, qd
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2006-12-01
End date: 2007-01-18
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from Japan on 2007-10-06
Patient: female
Adverse reactions / side effects: Back Pain, Diarrhoea, Injection Site Pain, Meningitis Viral, Skin Tightness
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in 61 year old male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-05
Patient: 61 year old male, weighing 88.0 kg (193.6 pounds)
Adverse reactions / side effects: Blood Urea Increased, Cellulitis, Diabetes Mellitus, Hyperglycaemia, Lymphopenia, Pain, General Physical Health Deterioration, Hyponatraemia, Insomnia, NO Therapeutic Response, Blood Sodium Increased, Hypoalbuminaemia, Depression, Peripheral Motor Neuropathy, Myopathy Steroid
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: once
Indication: Muscular Weakness
Start date: 2007-02-01
End date: 2007-02-01
Temozolomide
Dosage: po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2006-12-01
End date: 2007-01-18
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from Norway on 2007-10-05
Patient: male
Adverse reactions / side effects: Dysphagia, Muscular Weakness
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Other drugs received by patient: Enalapril Maleate; Enanton Depot SET; Allopur; Hydrochlorothiazide
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from United States on 2007-07-31
Patient: female
Adverse reactions / side effects: Migraine, Drug Ineffective
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-07-30
Patient: female
Adverse reactions / side effects: Dysphagia, Hepatic Failure, Rash
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-07-24
Patient: male
Adverse reactions / side effects: Rash Generalised, Chills, Pyrexia, Somnolence, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from United States on 2007-07-13
Patient: male, weighing 20.0 kg (44.0 pounds)
Adverse reactions / side effects: Pneumonia Aspiration, Dysphagia, Eyelid Ptosis, Asthenia, Botulism, Lethargy
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: 600 units, single
Indication: Muscle Spasticity
Start date: 2007-04-23
End date: 2007-04-23
Botox
Botox
Other drugs received by patient: Sinemet; Depakote; Leucovorin Calcium
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-06-22
Patient: female
Adverse reactions / side effects: Mass, Blood Blister, Musculoskeletal Stiffness, Headache, Swollen Tongue, Throat Tightness
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: 350 units, single
Indication: Torticollis
Start date: 2006-12-01
End date: 2006-12-01
Botox
Dosage: 350 units, single
Start date: 2007-03-12
End date: 2007-03-12
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from United States on 2007-06-22
Patient: male, weighing 20.0 kg (44.0 pounds)
Adverse reactions / side effects: Pneumonia Aspiration, Dysphagia, Eyelid Ptosis, Asthenia, Botulism, Lethargy
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: 600 units, single
Indication: Muscle Spasticity
Start date: 2007-04-23
End date: 2007-04-23
Botox
Botox
Other drugs received by patient: Sinemet; Depakote; Leucovorin Calcium
Adverse event in receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from United States on 2007-06-21
Patient:
Adverse reactions / side effects: Mechanical Ventilation
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from United States on 2007-06-15
Patient: male, weighing 20.0 kg (44.0 pounds)
Adverse reactions / side effects: Pneumonia Aspiration, Dysphagia, Eyelid Ptosis, Asthenia, Botulism, Lethargy
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: 600 units, single
Indication: Muscle Spasticity
Start date: 2007-04-23
End date: 2007-04-23
Botox
Botox
Other drugs received by patient: Sinemet; Depakote; Leucovorin Calcium
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from United States on 2007-06-14
Patient: male, weighing 20.0 kg (44.0 pounds)
Adverse reactions / side effects: Pneumonia Aspiration, Dysphagia, Eyelid Ptosis, Asthenia, Botulism, Lethargy
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: 600 units, single
Indication: Muscle Spasticity
Start date: 2007-04-23
End date: 2007-04-23
Botox
Botox
Other drugs received by patient: Sinemet; Depakote; Leucovorin Calcium
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from Canada on 2007-06-14
Patient: male
Adverse reactions / side effects: Migraine, Vision Blurred, Pyrexia, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Other drugs received by patient: Lorazepam
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from Germany on 2007-06-14
Patient: male
Adverse reactions / side effects: Epilepsy
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in 9 year old male receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from Australia on 2007-06-12
Patient: 9 year old male
Adverse reactions / side effects: Dysphagia, Dyspnoea, Pneumonia, Vomiting, Stridor, Laryngeal Obstruction, Obstructive Airways Disorder, Haematemesis
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: 400 units, unk
Indication: Cerebral Palsy
Start date: 2004-07-01
End date: 2004-07-01
Botox
Dosage: 400 units, unk
Start date: 2005-01-01
End date: 2005-01-01
Botox
Dosage: 400 units, unk
Start date: 2005-08-01
End date: 2005-08-01
Botox
Dosage: 400 units, unk
Start date: 2005-12-01
End date: 2005-12-01
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from Canada on 2007-06-08
Patient: male
Adverse reactions / side effects: Migraine, Vision Blurred, Pyrexia, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Other drugs received by patient: Lorazepam
Page 1 Next >>
|
